{"id":"https://openalex.org/W1970587349","doi":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","title":"Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial","display_name":"Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial","alternate_titles":[],"publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W1970587349","doi":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","mag":"1970587349","pmid":"https://pubmed.ncbi.nlm.nih.gov/17876196"},"language":"en","primary_location":{"id":"doi:10.2459/01.jcm.0000289271.80180.b6","doi":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","is_oa":false,"landing_page_url":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","pdf_url":null,"source":{"id":"https://openalex.org/S90613825","display_name":"Journal of Cardiovascular Medicine","issn_l":"1558-2027","issn":["1558-2027","1558-2035"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1970587349"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108256736","display_name":"Roberto Marchioli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]},{"id":"https://openalex.org/I4210110338","display_name":"Mario Negri Sud Foundation","ror":"https://ror.org/01qd3xc93","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210110338"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roberto Marchioli","raw_affiliation_strings":["Consorzio Mario Negri Sud, Santa Maria Imbaro (CH), Italy. marchioli@negrisud.it","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","e-mail: [email\u00a0protected]","fax: +39 0872 570206","to Dr Roberto Marchioli, Consorzio Mario Negri Sud, Via Nazionale 8/A, 66030 Santa Maria Imbaro (CH), Italy Tel: +39 0872 570252"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consorzio Mario Negri Sud, Santa Maria Imbaro (CH), Italy. marchioli@negrisud.it","institution_ids":[]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +39 0872 570206","institution_ids":[]},{"raw_affiliation_string":"to Dr Roberto Marchioli, Consorzio Mario Negri Sud, Via Nazionale 8/A, 66030 Santa Maria Imbaro (CH), Italy Tel: +39 0872 570252","institution_ids":["https://openalex.org/I4210110338"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110027046","display_name":"Rosa Maria Marfisi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosa Maria Marfisi","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047050431","display_name":"Giovanna Borrelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giovanna Borrelli","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068607655","display_name":"Carmelo Chieffo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carmelo Chieffo","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107880702","display_name":"Maria Grazia Franzosi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Grazia Franzosi","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008406413","display_name":"Giacomo Levantesi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giacomo Levantesi","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088186128","display_name":"Aldo Pietro Maggioni","orcid":"https://orcid.org/0000-0003-2764-6779","observed_orcids":["https://orcid.org/0000-0003-2764-6779"]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aldo Pietro Maggioni","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022436940","display_name":"Gian Luigi Nicolosi","orcid":"https://orcid.org/0000-0002-2218-2808","observed_orcids":["https://orcid.org/0000-0002-2218-2808"]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gian Luigi Nicolosi","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069807767","display_name":"Marco Scarano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marco Scarano","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108412760","display_name":"Maria Giuseppina Silletta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Giuseppina Silletta","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044932940","display_name":"Carlo Schweiger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlo Schweiger","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029606867","display_name":"Luigi Tavazzi","orcid":"https://orcid.org/0000-0003-4448-5209","observed_orcids":["https://orcid.org/0000-0003-4448-5209"]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luigi Tavazzi","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111939204","display_name":"Gianni Tognoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095959","display_name":"Associazione Nazionale Medici Cardiologi Ospedalieri","ror":"https://ror.org/00pyc4352","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210095959"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gianni Tognoni","raw_affiliation_strings":["The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999; 354:447\u2013455 [7]","institution_ids":[]},{"raw_affiliation_string":"The current work had no economic support. GISSI is endorsed by Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Florence, Italy, by Istituto di Ricerche Farmacologiche \u2018Mario Negri\u2019, Milan, Italy, and by Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. The GISSI-Prevenzione Group had the full responsibility for the study design, conduct, collection, management, analysis, interpretation of data, preparation, review, and approval of the manuscript. The GISSI-Prevenzione trial was supported by grants from Bristol\u2013Myers Squibb, Pharmacia\u2013Upjohn, Societ\u00e0 Prodotti Antibiotici, and Pfizer","institution_ids":["https://openalex.org/I4210095959"]},{"raw_affiliation_string":"All authors declare no conflict of interest, except institutional grants for the conduction of the Rischio&Prevenzione and GISSI-HF trials","institution_ids":[]},{"raw_affiliation_string":"The complete listing of the GISSI-Prevenzione Investigators is reported in Lancet 1999","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108256736"],"corresponding_institution_ids":["https://openalex.org/I4210095959","https://openalex.org/I4210110338"],"apc_list":null,"apc_paid":null,"fwci":1.9367,"has_fulltext":false,"cited_by_count":33,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83224261,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"8","issue":"Suppl 1","first_page":"S34","last_page":"S37"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10866","display_name":"Nutritional Studies and Diet","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9110000133514404},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.7620000243186951},{"id":"https://openalex.org/keywords/generalizability-of-trial-results","display_name":"generalizability of trial results","score":0.6940000057220459},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8669999837875366},{"id":"https://openalex.org/keywords/eating-habits","display_name":"dietary habits","score":0.9539999961853027},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.8040000200271606},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5289999842643738},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9708285331726074},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7859284281730652},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.6904653310775757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5518086552619934},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5274206399917603},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4955860376358032},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3603740930557251},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.15813511610031128},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014810","descriptor_name":"Vitamin E","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014815","descriptor_name":"Vitamins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015525","descriptor_name":"Fatty Acids, Omega-3","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018879","descriptor_name":"Ventricular Premature Complexes","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019587","descriptor_name":"Dietary Supplements","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2459/01.jcm.0000289271.80180.b6","doi":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","is_oa":false,"landing_page_url":"https://doi.org/10.2459/01.jcm.0000289271.80180.b6","pdf_url":null,"source":{"id":"https://openalex.org/S90613825","display_name":"Journal of Cardiovascular Medicine","issn_l":"1558-2027","issn":["1558-2027","1558-2035"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Medicine","raw_type":"journal-article"},{"id":"pmid:17876196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17876196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular medicine (Hagerstown, Md.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1985761375","https://openalex.org/W2014226775","https://openalex.org/W2025082537","https://openalex.org/W2033283286","https://openalex.org/W2049519185","https://openalex.org/W2087878463","https://openalex.org/W2088451948","https://openalex.org/W2097430843","https://openalex.org/W2103582851","https://openalex.org/W2104049876","https://openalex.org/W2112999163","https://openalex.org/W2128788220","https://openalex.org/W2192223169","https://openalex.org/W2334851064","https://openalex.org/W4232987596"],"related_works":["https://openalex.org/W4252050530","https://openalex.org/W2070156798","https://openalex.org/W2103582851","https://openalex.org/W2097430843","https://openalex.org/W3028463670","https://openalex.org/W2192223169","https://openalex.org/W2128788220","https://openalex.org/W2322868336"],"abstract_inverted_index":{"The":[0,21],"GISSI-Prevenzione":[1,40],"trial":[2],"established":[3],"the":[4,39,57,79],"efficacy":[5,58],"of":[6,23,59,82,88],"n-3":[7,60,83],"polyunsaturated":[8],"fatty":[9],"acids":[10],"(PUFAs)":[11],"for":[12],"reducing":[13],"mortality":[14],"in":[15,86],"patients":[16],"after":[17],"recent":[18,89],"myocardial":[19,90],"infarction.":[20,91],"generalisability":[22],"such":[24],"results":[25],"to":[26,32,42,63],"clinical":[27],"practice":[28],"could":[29,54],"vary":[30],"according":[31],"other":[33,45],"individual":[34],"patient":[35],"characteristics.":[36],"We":[37,67],"analysed":[38],"database":[41],"assess":[43],"whether":[44],"major":[46],"risk":[47],"factors,":[48],"comorbidities,":[49],"dietary":[50],"habits,":[51,75],"or":[52,76],"medications":[53],"interact":[55],"with":[56],"PUFA":[61,84],"treatment":[62],"reduce":[64],"total":[65],"mortality.":[66],"found":[68],"no":[69],"evidence":[70],"that":[71],"concomitant":[72],"disease":[73],"states,":[74],"interventions":[77],"altered":[78],"therapeutic":[80],"benefit":[81],"consumption":[85],"survivors":[87]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1970587349","counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
